NCT01315340

Brief Summary

Ocular rigidity characterizes the relationship between pressure and volume changes in the human eye and is expressed as a macroscopic coefficient. Outflow facility is a measure of the resistance of the conventional outflow pathway and represents a parameter that is of interest in glaucoma. Difficulties in the measurement of ocular rigidity in the living human eye have limited our knowledge on this parameter. However, ocular biomechanics have been implicated in the pathogenesis of this disease. The aim of this study is to characterize the pressure volume relation and quantify ocular rigidity and outflow facility in glaucomatous and normal eyes. For this purpose, the investigators have recently developed a manometric method for the measurement of ocular rigidity and outflow facility.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2011

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2011

Completed
8 days until next milestone

First Submitted

Initial submission to the registry

March 9, 2011

Completed
6 days until next milestone

First Posted

Study publicly available on registry

March 15, 2011

Completed
12 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2023

Completed
1.3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2024

Completed
Last Updated

August 16, 2022

Status Verified

August 1, 2022

Enrollment Period

12 years

First QC Date

March 9, 2011

Last Update Submit

August 15, 2022

Conditions

Outcome Measures

Primary Outcomes (2)

  • Ocular rigidity coefficient

    2 minutes measurement of ocular rigidity

  • Outflow facility coefficient

    3-4 minutes measurement of outflow facility

Secondary Outcomes (2)

  • Ocular pulse amplitude

    6 minutes

  • Pulsatile ocular blood flow

    6 minutes

Study Arms (2)

Glaucoma Patients

EXPERIMENTAL
Procedure: Ocular rigidity, outflow facility and intraocular pressure measurement

Control subjects

ACTIVE COMPARATOR
Procedure: Ocular rigidity, outflow facility and intraocular pressure measurement

Interventions

The measurement procedure includes cannulation of the anterior chamber of the eye, under sterile conditions. Infusion of the eye with microvolumes of a saline solution is performed, followed by manometric measurement of intraocular pressure, in order to quantify ocular rigidity. Outflow facility is estimated from recordings of intraocular pressure after the infusion is stopped.

Control subjectsGlaucoma Patients

Eligibility Criteria

Age40 Years - 90 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with primary open or pseudoexfoliation glaucoma that are undergoing cataract surgery
  • Patients undergoing cataract surgery without evidence of other ocular disease.

You may not qualify if:

  • Previous ophthalmic surgery or trauma
  • Significant visual field defect (MD\<-12dB) or an increased cup to disc ratio (\>0.9).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ophthalmology Department, University Hospital of Larissa

Larissa, 41110, Greece

RECRUITING

Related Publications (6)

  • Dastiridou AI, Ginis HS, De Brouwere D, Tsilimbaris MK, Pallikaris IG. Ocular rigidity, ocular pulse amplitude, and pulsatile ocular blood flow: the effect of intraocular pressure. Invest Ophthalmol Vis Sci. 2009 Dec;50(12):5718-22. doi: 10.1167/iovs.09-3760. Epub 2009 Jul 15.

    PMID: 19608534BACKGROUND
  • Pallikaris IG, Kymionis GD, Ginis HS, Kounis GA, Christodoulakis E, Tsilimbaris MK. Ocular rigidity in patients with age-related macular degeneration. Am J Ophthalmol. 2006 Apr;141(4):611-5. doi: 10.1016/j.ajo.2005.11.010.

    PMID: 16564793BACKGROUND
  • Pallikaris IG, Kymionis GD, Ginis HS, Kounis GA, Tsilimbaris MK. Ocular rigidity in living human eyes. Invest Ophthalmol Vis Sci. 2005 Feb;46(2):409-14. doi: 10.1167/iovs.04-0162.

    PMID: 15671262BACKGROUND
  • Dastiridou AI, Ginis H, Tsilimbaris M, Karyotakis N, Detorakis E, Siganos C, Cholevas P, Tsironi EE, Pallikaris IG. Ocular rigidity, ocular pulse amplitude, and pulsatile ocular blood flow: the effect of axial length. Invest Ophthalmol Vis Sci. 2013 Mar 1;54(3):2087-92. doi: 10.1167/iovs.12-11576.

    PMID: 23462745BACKGROUND
  • Dastiridou AI, Tsironi EE, Tsilimbaris MK, Ginis H, Karyotakis N, Cholevas P, Androudi S, Pallikaris IG. Ocular rigidity, outflow facility, ocular pulse amplitude, and pulsatile ocular blood flow in open-angle glaucoma: a manometric study. Invest Ophthalmol Vis Sci. 2013 Jul 10;54(7):4571-7. doi: 10.1167/iovs.13-12303.

    PMID: 23761082BACKGROUND
  • Karyotakis NG, Ginis HS, Dastiridou AI, Tsilimbaris MK, Pallikaris IG. Manometric measurement of the outflow facility in the living human eye and its dependence on intraocular pressure. Acta Ophthalmol. 2015 Aug;93(5):e343-e348. doi: 10.1111/aos.12652. Epub 2015 Feb 1.

    PMID: 25645503BACKGROUND

MeSH Terms

Conditions

Glaucoma

Interventions

Intraocular Pressure

Condition Hierarchy (Ancestors)

Ocular HypertensionEye Diseases

Intervention Hierarchy (Ancestors)

Ocular Physiological Phenomena

Study Officials

  • Ioannis Pallikaris, MD

    University of Crete

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Ioannis Pallikaris, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD, PhD

Study Record Dates

First Submitted

March 9, 2011

First Posted

March 15, 2011

Study Start

March 1, 2011

Primary Completion

March 1, 2023

Study Completion

July 1, 2024

Last Updated

August 16, 2022

Record last verified: 2022-08

Locations